… treatments. In this study, we systematically reviewed all topically applied treatment options
for external genital warts that were studied in at least one RCT and met our eligibility criteria. …

… , a patient-applied immune-response modifier for treatment of external genital warts. … in
children with topical 0.05% podofilox gel and 5% imiquimod cream. Pediatric dermatology…

… This is a patient-applied therapy… (podofilox) during pregnancy and in the vagina or cervix
at any time [132]. In a randomised comparative study, 60 women with genital warts were treated …

… 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, which are
sexually transmitted. There were 122,068 episodes of new or recurrent genital warts treated in …

… Podofilox was found to be more effective and economical … used to treat other forms of warts
their utility in genital warts is … , a patient-applied immune-response modifier for treatment of …

… No hierarchy of first-line treatments for anogenital warts (AGWs) is provided in international
… the efficacy of topical treatments and ablative procedures for the management of AGWs. …

… aimed to determine the efficacy and safety of local treatments for the management of AGWs.
… of treatments. Nevertheless, our results provide an overview of the main AGW treatments …

… , 6) due to coinfection, but there is no evidence that high risk HPV types cause genital warts.
Anogenital … Imiquimod, a patient-applied immune-response modifier for treatment of external …

… patients with genital warts, reports that most patients would have preferred to be treated with
… clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital …

… Patient-administered treatments are centered on a regular application of podofilox, …
Combination treatment starting with ablative therapy by a provider followed by patient-applied …